Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell

E Anne Lown1, Anu Banerjee2, Eric Vittinghoff3

  • 1Social and Behavioral Sciences, School of Nursing, University of California, San Francisco, California.

Insights

This study explored acupressure for children undergoing cancer treatment or stem cell transplants. Acupressure may help manage treatment side effects like nausea and pain in pediatric patients.

Area of Science:

  • Pediatric Oncology
  • Integrative Medicine
  • Clinical Trials

Background:

  • A pragmatic randomized controlled trial (RCT) named Acupressure for Children in Treatment for a Childhood Cancer (ACT-CC) was designed.
  • The study protocol focuses on evaluating acupressure's role in managing symptoms for children undergoing cancer treatment or hematopoietic stem cell transplant (HSCT).

Purpose of the Study:

  • To assess the feasibility and effectiveness of an acupressure intervention.
  • To reduce treatment-related symptoms in pediatric cancer patients and HSCT recipients.

Main Methods:

  • A two-armed RCT involving 85 children and their caregivers across two pediatric teaching hospitals.
  • Participants were randomized to receive usual care plus daily professional and caregiver-delivered acupressure or usual care alone.
  • The intervention included up to 20 professional acupressure treatments.

Main Results:

  • The primary outcome was a composite measure of nausea and vomiting in children.
  • Secondary outcomes included child's nausea, vomiting, pain, fatigue, depression, anxiety, and positive affect.
  • Parental outcomes such as depression, anxiety, posttraumatic stress symptoms, and self-efficacy were also assessed.

Conclusions:

  • The trial results can inform childhood cancer and HSCT centers on integrating acupressure providers for symptom management.
  • This research could guide the routine inclusion of acupressure to improve patient care and outcomes.
Abstract

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K